Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.

One strategy for a functional cure of HIV-1 is "block and lock", which seeks to permanently suppress the rebound of quiescent HIV-1 by epigenetic silencing. For the bivalent promoter in the HIV LTR, both histone 3 lysine 27 tri-methylation (H3K27me3) and DNA methylation are associated with...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kien Nguyen, Curtis Dobrowolski, Meenakshi Shukla, Won-Kyung Cho, Benjamin Luttge, Jonathan Karn
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/978c6c5fe8664892ac69b57b94c08f28
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:978c6c5fe8664892ac69b57b94c08f28
record_format	dspace
spelling	oai:doaj.org-article:978c6c5fe8664892ac69b57b94c08f282021-12-02T19:59:59ZInhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.1553-73661553-737410.1371/journal.ppat.1010014https://doaj.org/article/978c6c5fe8664892ac69b57b94c08f282021-10-01T00:00:00Zhttps://doi.org/10.1371/journal.ppat.1010014https://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374One strategy for a functional cure of HIV-1 is "block and lock", which seeks to permanently suppress the rebound of quiescent HIV-1 by epigenetic silencing. For the bivalent promoter in the HIV LTR, both histone 3 lysine 27 tri-methylation (H3K27me3) and DNA methylation are associated with viral suppression, while H3K4 tri-methylation (H3K4me3) is correlated with viral expression. However, H3K27me3 is readily reversed upon activation of T-cells through the T-cell receptor. In an attempt to suppress latent HIV-1 in a stable fashion, we knocked down the expression or inhibited the activity of UTX/KDM6A, the major H3K27 demethylase, and investigated its impact on latent HIV-1 reactivation in T cells. Inhibition of UTX dramatically enhanced H3K27me3 levels at the HIV LTR and was associated with increased DNA methylation. In latently infected cells from patients, GSK-J4, which is a potent dual inhibitor of the H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A, effectively suppressed the reactivation of latent HIV-1 and also induced DNA methylation at specific sites in the 5'LTR of latent HIV-1 by the enhanced recruitment of DNMT3A to HIV-1. Nonetheless, suppression of HIV-1 through epigenetic silencing required the continued treatment with GSK-J4 and was rapidly reversed after removal of the drug. DNA methylation was also rapidly lost after removal of drug, suggesting active and rapid DNA-demethylation of the HIV LTR. Thus, induction of epigenetic silencing by histone and DNA methylation appears to be insufficient to permanently silence HIV-1 proviral transcription.Kien NguyenCurtis DobrowolskiMeenakshi ShuklaWon-Kyung ChoBenjamin LuttgeJonathan KarnPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 17, Iss 10, p e1010014 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5
spellingShingle	Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 Kien Nguyen Curtis Dobrowolski Meenakshi Shukla Won-Kyung Cho Benjamin Luttge Jonathan Karn Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.
description	One strategy for a functional cure of HIV-1 is "block and lock", which seeks to permanently suppress the rebound of quiescent HIV-1 by epigenetic silencing. For the bivalent promoter in the HIV LTR, both histone 3 lysine 27 tri-methylation (H3K27me3) and DNA methylation are associated with viral suppression, while H3K4 tri-methylation (H3K4me3) is correlated with viral expression. However, H3K27me3 is readily reversed upon activation of T-cells through the T-cell receptor. In an attempt to suppress latent HIV-1 in a stable fashion, we knocked down the expression or inhibited the activity of UTX/KDM6A, the major H3K27 demethylase, and investigated its impact on latent HIV-1 reactivation in T cells. Inhibition of UTX dramatically enhanced H3K27me3 levels at the HIV LTR and was associated with increased DNA methylation. In latently infected cells from patients, GSK-J4, which is a potent dual inhibitor of the H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A, effectively suppressed the reactivation of latent HIV-1 and also induced DNA methylation at specific sites in the 5'LTR of latent HIV-1 by the enhanced recruitment of DNMT3A to HIV-1. Nonetheless, suppression of HIV-1 through epigenetic silencing required the continued treatment with GSK-J4 and was rapidly reversed after removal of the drug. DNA methylation was also rapidly lost after removal of drug, suggesting active and rapid DNA-demethylation of the HIV LTR. Thus, induction of epigenetic silencing by histone and DNA methylation appears to be insufficient to permanently silence HIV-1 proviral transcription.
format	article
author	Kien Nguyen Curtis Dobrowolski Meenakshi Shukla Won-Kyung Cho Benjamin Luttge Jonathan Karn
author_facet	Kien Nguyen Curtis Dobrowolski Meenakshi Shukla Won-Kyung Cho Benjamin Luttge Jonathan Karn
author_sort	Kien Nguyen
title	Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.
title_short	Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.
title_full	Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.
title_fullStr	Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.
title_full_unstemmed	Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.
title_sort	inhibition of the h3k27 demethylase utx enhances the epigenetic silencing of hiv proviruses and induces hiv-1 dna hypermethylation but fails to permanently block hiv reactivation.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/978c6c5fe8664892ac69b57b94c08f28
work_keys_str_mv	AT kiennguyen inhibitionoftheh3k27demethylaseutxenhancestheepigeneticsilencingofhivprovirusesandinduceshiv1dnahypermethylationbutfailstopermanentlyblockhivreactivation AT curtisdobrowolski inhibitionoftheh3k27demethylaseutxenhancestheepigeneticsilencingofhivprovirusesandinduceshiv1dnahypermethylationbutfailstopermanentlyblockhivreactivation AT meenakshishukla inhibitionoftheh3k27demethylaseutxenhancestheepigeneticsilencingofhivprovirusesandinduceshiv1dnahypermethylationbutfailstopermanentlyblockhivreactivation AT wonkyungcho inhibitionoftheh3k27demethylaseutxenhancestheepigeneticsilencingofhivprovirusesandinduceshiv1dnahypermethylationbutfailstopermanentlyblockhivreactivation AT benjaminluttge inhibitionoftheh3k27demethylaseutxenhancestheepigeneticsilencingofhivprovirusesandinduceshiv1dnahypermethylationbutfailstopermanentlyblockhivreactivation AT jonathankarn inhibitionoftheh3k27demethylaseutxenhancestheepigeneticsilencingofhivprovirusesandinduceshiv1dnahypermethylationbutfailstopermanentlyblockhivreactivation
_version_	1718375738905722880

Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.

Ejemplares similares